Cardiothoracic & vascular anesthesia

Use of Hydroxycobolamin in the Prevention of Vasoplegic Syndrome in Adult Patients Undergoing Cardiopulmonary Bypass: A Controlled Prospective Trial

J Cardiothorac Vasc AnesthPublished Randomised controlled trial

Authors' conclusion

This study showed that prophylactic hydroxocobalamin can be used effectively to decrease the incidence of vasoplegic syndrome, and total vasopressor dose, as well as improve tissue perfusion in high-risk patients in cardiac surgeries.

Study context

Population
Adults 18–60 years at high risk of vasoplegia (≥2 preoperative risk factors) undergoing coronary artery bypass grafting (CABG) and/or valve surgery on cardiopulmonary bypass (CPB)
Participants
30 vs 30
Comparison
Hydroxocobalamin 5 g IV vs normal saline at end of CPB
  • Group In = 30
  • Group IIn = 30reference
Primary endpoint
Change in MAP between baseline and all time points (30 and 60 minutes after CPB initiation and 30 and 60 minutes after CPB separation)
Methodological detailsplacebo-controlled, prospective, single-centre, Ain Shams University Hospitals, August 2019 to October 2023
  • Placebo-controlled
  • Prospective
  • Single-centre
  • Ain Shams University Hospitals, August 2019 to October 2023

Primary result

As reported in the abstract

MAP · 30 and 60 minutes after CPB separation
  • MAP significantly higher in group I vs group II

Further findings

Systemic venous resistance · 30 and 60 minutes after CPB separation

Significantly higher in group I vs group II

Cardiac index

Significantly lower in group I vs group II

Norepinephrine requirements and average total dose norepinephrine equivalent · 30 and 60 minutes after CPB separation

Significantly lower in group I

Serum lactate

Significantly lower in group I

Vasoplegic shock syndrome and norepinephrine-resistant refractory vasoplegia

Less frequent in group I; difference statistically significant

Ventilator days, ICU LOS, hospital LOS

Less frequent in group I; differences not statistically significant

Safety

AKI, shock liver and mortality · 1 week

Less frequent in group I; differences not statistically significant

Original publication

Use of Hydroxycobolamin in the Prevention of Vasoplegic Syndrome in Adult Patients Undergoing Cardiopulmonary Bypass: A Controlled Prospective Trial. J Cardiothorac Vasc Anesth. Published 5 February 2025. doi:10.1053/j.jvca.2025.02.001

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.